BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38288798)

  • 1. Artificial Intelligence Technologies used for the Assessment of Pharmaceutical Excipients.
    Kumar A; Gupta GD; Raikwar S
    Curr Pharm Des; 2024; 30(6):407-409. PubMed ID: 38288798
    [No Abstract]   [Full Text] [Related]  

  • 2. The comprehensive profiling of drug substances and pharmaceutical excipients. Preface.
    Brittain HG
    Profiles Drug Subst Excip Relat Methodol; 2013; 38():xi. PubMed ID: 23668412
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrating artificial and human intelligence into tablet production process.
    Gams M; Horvat M; Ožek M; Luštrek M; Gradišek A
    AAPS PharmSciTech; 2014 Dec; 15(6):1447-53. PubMed ID: 24970587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of an artificial intelligence technology--Model trees. Novel applications for an immediate release tablet formulation database.
    Shao Q; Rowe RC; York P
    Eur J Pharm Sci; 2007 Jun; 31(2):137-44. PubMed ID: 17452096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable isotope-labeled excipients for drug product identification and counterfeit detection.
    Felton LA; Shah PP; Sharp Z; Atudorei V; Timmins GS
    Drug Dev Ind Pharm; 2011 Jan; 37(1):88-92. PubMed ID: 20560792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of various analytical techniques in quality control of pharmaceutical excipients.
    Kumar M; Bhatia R; Rawal RK
    J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preface to volume 39.
    Brittain HG
    Profiles Drug Subst Excip Relat Methodol; 2014; 39():ix. PubMed ID: 24794913
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of Propellants and Excipients in Pharmaceutical Topical Aerosol.
    Patra M; Bhattacharya S; Patnaik M
    Curr Drug Deliv; 2017; 14(8):1106-1113. PubMed ID: 28290242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excipient variability and its impact on dosage form functionality.
    Dave VS; Saoji SD; Raut NA; Haware RV
    J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of beneficial interactions between active medicaments and excipients in pharmaceutical formulations.
    Kalinkova GN
    Int J Pharm; 1999 Sep; 187(1):1-15. PubMed ID: 10502611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preface to Volume 42.
    Profiles Drug Subst Excip Relat Methodol; 2017; 42():xi. PubMed ID: 28431782
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical co-crystals-an opportunity for drug product enhancement.
    Miroshnyk I; Mirza S; Sandler N
    Expert Opin Drug Deliv; 2009 Apr; 6(4):333-41. PubMed ID: 19348603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro hemolysis: guidance for the pharmaceutical scientist.
    Amin K; Dannenfelser RM
    J Pharm Sci; 2006 Jun; 95(6):1173-6. PubMed ID: 16639718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preface to Volume 40.
    Brittain HG
    Profiles Drug Subst Excip Relat Methodol; 2015; 40():ix-xii. PubMed ID: 26051691
    [No Abstract]   [Full Text] [Related]  

  • 15. Challenges of pediatric formulations: a FDA science perspective.
    Gupta A; Khan MA
    Int J Pharm; 2013 Nov; 457(1):346-8. PubMed ID: 24216242
    [No Abstract]   [Full Text] [Related]  

  • 16. Carrageenan as an efficient drug release modifier for ethylcellulose-coated pharmaceutical dosage forms.
    Siepmann F; Muschert S; Zach S; Leclercq B; Carlin B; Siepmann J
    Biomacromolecules; 2007 Dec; 8(12):3984-91. PubMed ID: 18039003
    [No Abstract]   [Full Text] [Related]  

  • 17. A new paradigm for improving oral absorption of drugs in discovery: role of physicochemical properties, different excipients and the pharmaceutical scientist.
    Wilson AG; Nouraldeen A; Gopinathan S
    Future Med Chem; 2010 Jan; 2(1):1-5. PubMed ID: 21426039
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of organic volatile impurities in pharmaceutical excipients by static headspace capillary gas chromatography.
    Fliszar K; Wiggins JM; Pignoli CM; Martin GP; Li Z
    J Chromatogr A; 2004 Feb; 1027(1-2):83-91. PubMed ID: 14971487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of small molecule drugs, excipients and counter ions in pharmaceuticals by capillary electromigration methods - recent developments.
    Zhu Q; Scriba GKE
    J Pharm Biomed Anal; 2018 Jan; 147():425-438. PubMed ID: 28711220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ¹³C solid-state NMR analysis of the most common pharmaceutical excipients used in solid drug formulations, Part I: Chemical shifts assignment.
    Pisklak DM; Zielińska-Pisklak MA; Szeleszczuk Ł; Wawer I
    J Pharm Biomed Anal; 2016 Apr; 122():81-9. PubMed ID: 26845204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.